9,10-dimethyl-1,2-benzanthracene has been researched along with Acute Lymphoid Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archuleta, MM; Burchiel, SW; Deanin, GG; Ledbetter, JA; Schieven, GL | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
7,12-Dimethylbenz[a]anthracene activates protein-tyrosine kinases Fyn and Lck in the HPB-ALL human T-cell line and increases tyrosine phosphorylation of phospholipase C-gamma 1, formation of inositol 1,4,5-trisphosphate, and mobilization of intracellular
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Calcium; CD3 Complex; CD4 Antigens; Humans; Inositol 1,4,5-Trisphosphate; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mice; Mice, Inbred BALB C; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; T-Lymphocytes; Tumor Cells, Cultured; Type C Phospholipases; Tyrosine | 1993 |